Publication not explained

This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.

If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.

Featured Image

Read the Original

This page is a summary of: Formulation and in-vitro evaluation of directly compressed controlled release matrices of Losartan Potassium using Ethocel Grade 100 as rate retarding agent, International Journal of Pharmaceutics, December 2015, Elsevier,
DOI: 10.1016/j.ijpharm.2015.10.051.
You can read the full text:

Read

Contributors

The following have contributed to this page